GenMark Diagnostics (GNMK) Prices 7.254M Share Common Offering at $9.65/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
GenMark Diagnostics (GNMK) to Offer Common Stock
May 6, 2020 5:33 PM EDTGenMark Diagnostics, Inc. (NASDAQ: GNMK) announced today that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by GenMark. GenMark intends to grant the underwriters a 30-day... More
GenMark Diagnostics (GNMK) PT Raised to $16 at Canaccord Genuity
May 5, 2020 8:01 AM EDTCanaccord Genuity analyst Max Masucci raised the price target on GenMark Diagnostics (NASDAQ: GNMK) to $16.00 (from $15.00) while maintaining a Buy rating.... More



